Sonnet BioTherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SONN and other ETFs, options, and stocks.

About SONN

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. 

CEO
Pankaj Mohan
CEOPankaj Mohan
Employees
9
Employees9
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2011
Founded2011
Employees
9
Employees9

SONN Key Statistics

Market cap
4.46M
Market cap4.46M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
279.33K
Average volume279.33K
High today
$1.05
High today$1.05
Low today
$0.97
Low today$0.97
Open price
$1.02
Open price$1.02
Volume
224.48K
Volume224.48K
52 Week high
$9.37
52 Week high$9.37
52 Week low
$0.9689
52 Week low$0.9689

SONN Earnings

-$4.48
-$2.99
-$1.49
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Dec 16, Pre-Market
ActualExpected Dec 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.